# Pharmacokinetic Study of Levocetirizine Oral Solution

> **NCT01622283** · PHASE1 · COMPLETED · sponsor: **GlaxoSmithKline** · enrollment: 20 (actual)

## Conditions studied

- Rhinitis, Allergic, Perennial and Seasonal

## Interventions

- **DRUG:** Levocetirizine
- **DRUG:** Cetirizine

## Key facts

- **NCT ID:** NCT01622283
- **Lead sponsor:** GlaxoSmithKline
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2012-05-02
- **Primary completion:** 2012-06-10
- **Final completion:** 2012-06-10
- **Target enrollment:** 20 (ACTUAL)
- **Last updated:** 2017-06-12


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01622283

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01622283, "Pharmacokinetic Study of Levocetirizine Oral Solution". Retrieved via AI Analytics 2026-06-05 from https://api.ai-analytics.org/clinical/NCT01622283. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*